ES442051A1 - Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina. - Google Patents

Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina.

Info

Publication number
ES442051A1
ES442051A1 ES442051A ES442051A ES442051A1 ES 442051 A1 ES442051 A1 ES 442051A1 ES 442051 A ES442051 A ES 442051A ES 442051 A ES442051 A ES 442051A ES 442051 A1 ES442051 A1 ES 442051A1
Authority
ES
Spain
Prior art keywords
formula
compound
hydrogen atom
aminoglycosides
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES442051A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of ES442051A1 publication Critical patent/ES442051A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES442051A 1974-10-26 1975-10-24 Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina. Expired ES442051A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4641274A GB1464401A (en) 1974-10-26 1974-10-26 Aminoglycosides

Publications (1)

Publication Number Publication Date
ES442051A1 true ES442051A1 (es) 1977-04-01

Family

ID=10441164

Family Applications (1)

Application Number Title Priority Date Filing Date
ES442051A Expired ES442051A1 (es) 1974-10-26 1975-10-24 Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina.

Country Status (28)

Country Link
JP (1) JPS5519237B2 (es)
AR (1) AR205593A1 (es)
AT (1) AT340051B (es)
BE (1) BE834864A (es)
BG (1) BG24821A3 (es)
CA (1) CA1039275A (es)
CH (1) CH601339A5 (es)
CS (1) CS195712B2 (es)
DD (1) DD122522A5 (es)
DE (1) DE2547738C3 (es)
DK (1) DK147075C (es)
EG (1) EG11975A (es)
ES (1) ES442051A1 (es)
FI (1) FI752951A (es)
FR (1) FR2289202A1 (es)
GB (1) GB1464401A (es)
HU (1) HU172060B (es)
IE (1) IE42452B1 (es)
IL (1) IL48263A (es)
LU (1) LU73644A1 (es)
NL (1) NL162081C (es)
NZ (1) NZ179050A (es)
PH (1) PH12782A (es)
PL (1) PL99933B1 (es)
RO (1) RO72878A (es)
SE (1) SE7511945L (es)
SU (1) SU617017A3 (es)
ZA (1) ZA756326B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860513D1 (en) * 1977-06-24 1981-04-09 Scherico Ltd Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives
JPS5488241A (en) * 1977-12-21 1979-07-13 Kyowa Hakko Kogyo Co Ltd Novel fortimicin a derivative
JPS57118475U (es) * 1981-01-14 1982-07-22

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606076A5 (es) * 1973-08-06 1978-10-13 Scherico Ltd

Also Published As

Publication number Publication date
PH12782A (en) 1979-08-17
NZ179050A (en) 1978-03-06
DK147075C (da) 1984-11-05
NL7512465A (nl) 1976-04-28
IL48263A (en) 1978-03-10
ZA756326B (en) 1976-09-29
GB1464401A (en) 1977-02-16
AT340051B (de) 1977-11-25
CS195712B2 (en) 1980-02-29
JPS5168543A (es) 1976-06-14
IL48263A0 (en) 1975-12-31
EG11975A (en) 1978-06-30
SU617017A3 (ru) 1978-07-25
BG24821A3 (en) 1978-05-12
AR205593A1 (es) 1976-05-14
CA1039275A (en) 1978-09-26
LU73644A1 (es) 1977-05-31
HU172060B (hu) 1978-05-28
IE42452L (en) 1976-04-26
BE834864A (fr) 1976-04-26
DK481175A (da) 1976-04-27
RO72878B (ro) 1983-06-30
RO72878A (ro) 1983-07-07
PL99933B1 (pl) 1978-08-31
DE2547738C3 (de) 1978-08-03
DE2547738B2 (de) 1977-12-01
AU8598175A (en) 1976-12-09
CH601339A5 (es) 1978-07-14
DE2547738A1 (de) 1976-05-06
NL162081C (nl) 1980-04-15
DD122522A5 (es) 1976-10-12
ATA809575A (de) 1977-03-15
IE42452B1 (en) 1980-08-13
FR2289202B1 (es) 1978-11-10
DK147075B (da) 1984-04-02
NL162081B (nl) 1979-11-15
FI752951A (es) 1976-04-27
SE7511945L (sv) 1976-04-27
JPS5519237B2 (es) 1980-05-24
FR2289202A1 (fr) 1976-05-28

Similar Documents

Publication Publication Date Title
ES457050A1 (es) Un procedimiento para la preparacion de aminoacidos cicli- cos.
ES451979A1 (es) Un metodo de preparacion de compuestos antialergicos.
ES373753A1 (es) Un procedimiento para preparar benzoindenos.
ES442051A1 (es) Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina.
ES393934A2 (es) Procedimiento para la preparacion de derivados de teofili- na.
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ES429020A1 (es) Procedimiento para preparar nuevos derivados de tiazol-5- metanol.
ES452146A2 (es) Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina.
ES400414A1 (es) Procedimiento para la preparacion de derivados de piperidi-na n-sustituidos y su utilizacion como estabilizadores.
ES401342A1 (es) Procedimiento para la preparacion de nuevos derivados de lapiridina y de sus sales.
ES435351A1 (es) Procedimiento para preparar 1-(3-fenil-propil)-4-furoilpi- perazinas.
ES364980A1 (es) Un metodo para preparar nuevos derivados de adamantano.
ES437041A1 (es) Un procedimiento para preparar derivados de 1-ftalazona.
ES400623A1 (es) Procedimiento para la preparacion de una composicion farma-ceutica.
ES442612A1 (es) Procedimiento para la obtencion de nuevos derivados de iso- quinoleina.
ES391787A1 (es) Un procedimiento para preparar un compuesto de purina.
ES402642A1 (es) Procedimiento para la preparacion de nuevos esteres alcohi-licos de acido tiolcarbamidico basicamente sustituidos.
ES379617A1 (es) Procedimiento para la preparacion de aminoacidos.
ES393259A1 (es) Un procedimiento para la preparacion de derivados esterifi-cados de piridilbenzopiranos.
ES465366A2 (es) Un procedimiento de preparacion de derivados de metoxi-2- benzamidas.
ES405195A3 (es) Procedimiento de preparacion de combinaciones tipo acido 3,4, 5-trialcoxibenzoilaminoalcanocarboxilico y sus sales.
ES380389A1 (es) Procedimiento para la preparacion de 5 - nitro-2-furfurili-den-amino - oxazolidinonas.
ES306673A1 (es) Metodo de preparaciën de nuevas cistinil diamidas
ES345230A1 (es) Un procedimiento para preparar una composicion para reducirla presion de la sangre en sujetos hipertensos.
ES402551A1 (es) Un procedimiento para la preparacion de derivados de pipe- razina.